Prescription ·Moderate evidence ·Reviewed May 2026
Atenolol is a cardioselective beta-1 blocker used for hypertension and angina. It is hydrophilic and does not cross the blood-brain barrier readily, potentially causing fewer central nervous system side effects. However, it is no longer considered a first-line antihypertensive based on the LIFE trial showing inferiority to losartan for stroke prevention.
The bottom line
Evidence rating moderate. Most-documented uses: effective blood pressure reduction, reduces angina frequency, fewer cns side effects (hydrophilic). 10 sources indexed (2013–2025), with 7 interaction records on file.
Core mechanism
Selectively blocks beta-1 adrenergic receptors in the heart. Reduces heart rate, cardiac contractility, and cardiac output. Decreases renin secretion. Hydrophilic nature limits CNS penetration. Does not have intrinsic sympathomimetic activity or membrane-stabilizing properties.5
Can be taken with or without food; renally eliminated, requires dose adjustment in renal impairment
Nutrients this medication can lower over time, and what to replace.
Chronic beta-blocker therapy has been associated with lower tissue CoQ10 status and reduced mitochondrial electron transport support.
Beta-blockers suppress nocturnal melatonin production. Atenolol, being beta-1 selective, has a moderate effect on melatonin suppression. Supplementation may help with insomnia.
Recommendation: If experiencing insomnia on atenolol, melatonin 0.5-3mg at bedtime may help.
Like other beta-blockers, atenolol inhibits mitochondrial CoQ10-dependent enzymes, contributing to fatigue and reduced exercise tolerance. CoQ10 supplementation (100-200 mg/day) can replenish levels and may improve symptoms, with the added benefit of modest blood-pressure reduction in some patients.
Recommendation: Consider CoQ10 100-200 mg/day with food if you experience fatigue, exercise intolerance, or muscle aches on atenolol. Monitor blood pressure since CoQ10 can produce a small additional drop.
L-Arginine modestly lowers blood pressure through nitric oxide-mediated vasodilation. Stacked with atenolol's beta1 blockade, the combined drop can produce symptomatic hypotension, especially in older adults or those already well-controlled.
Recommendation: If you take atenolol, start L-arginine at lower doses (1-3 g/day) and monitor your blood pressure for 1-2 weeks. Reduce or stop if you develop dizziness, fatigue, or readings below your usual range.
Taurine lowers blood pressure modestly and has direct heart-rate-lowering effects. Combined with atenolol, the effects can be additive, producing further reductions in heart rate and blood pressure.
Recommendation: Taurine at 1-3 g/day is typically safe with atenolol but check resting heart rate and blood pressure when you start. Reduce the dose if HR drops below 50 bpm or you develop dizziness.
Aged garlic extract reduces systolic blood pressure by approximately 8 mmHg in hypertensives. Layered on atenolol, the combined effect can drive blood pressure below target, particularly in older patients prone to orthostatic symptoms.
Recommendation: If you take atenolol, monitor your blood pressure for 2-4 weeks after starting garlic extract. Have your prescriber re-evaluate your atenolol dose if your readings consistently fall below your target range.
Fish oil (EPA/DHA) at 2-3 g/day produces small reductions in blood pressure and lowers triglycerides, complementing atenolol's hemodynamic effects in patients with hypertension or cardiovascular disease.
Recommendation: Fish oil at 1-3 g/day is generally compatible with atenolol and may add cardiovascular benefit. Monitor blood pressure when starting, and let your prescriber know if you take high doses (>3 g/day).
Concentrated fish oil products deliver 2-3 g of EPA/DHA per softgel, which produces meaningful blood-pressure reductions on top of atenolol. The combination is generally beneficial but can over-shoot the BP target in well-controlled patients.
Recommendation: If you take atenolol and start a triple-strength fish oil product, monitor your blood pressure for 2-4 weeks. Have your prescriber re-evaluate the atenolol dose if your readings consistently fall below target.
Numbered references. Citations throughout the page link here.
Brandão AA, Rodrigues CIS, Nadruz W et al.. Systematic Review on the Efficacy of Atenolol in Antihypertensive Treatment: Recommendation from the Brazilian Society of Cardiology. Arquivos brasileiros de cardiologia. 2025
Bratton S, Taylor MK, Cortez P et al.. Does atenolol use during pregnancy cause small for gestational age neonates? A meta-analysis. Journal of perinatal medicine. 2024
Wang Q, Xiang B, Chen S et al.. Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review. The Australasian journal of dermatology. 2019
Kuyper LM, Khan NA. Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis. The Canadian journal of cardiology. 2014
DiNicolantonio JJ, Lavie CJ, Fares H et al.. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). The American journal of cardiology. 2013
Shi M, Wargon O, Tatian A. Efficacy and safety of atenolol vs. propranolol for treatment of infantile haemangioma: a narrative review. Clinical and experimental dermatology. 2025
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack